Purchase Order 75D30125P20375
Award Date
11/20/24
Potential Completion Date
11/19/28
Potential Value
$240K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The contract is for maintenance services on an unspecified range of Illumina's sequencing systems, including NextSeq, NovaSeq, MiSeq, and iSeq models. The contract has a ceiling value of $149,442.60 and an ultimate completion date of September 25, 2017. The contract does not have a set-aside...
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded to Illumina, Inc., a manufacturer of sequencing instruments and reagents, by the Centers for Disease Control and Prevention (CDC) Pittsburgh. The $67,395.38 award is for an "ILLUMINA PRODUCT CARE PLAN" to provide support and maintenance services for Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms used by the CDC. This award is not associated with a set-aside program. Illumina has a...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing systems and related products. The contract is for the maintenance, repair, and support of Illumina's NovaSeq 6000 and MiSeq sequencing instruments over a 2-year period, with a ceiling value of $139,336.76. This contract does not have a set-aside designation. Illumina has previously received prime federal contracts and...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for annual maintenance, repair, and support services for the CDC's Genomic Sequencing Laboratory's Illumina NovaSeq and MiSeq instruments. The $144,910.12 contract will provide full coverage of parts, labor, travel, reagent replacement, remote technical support, and on-site response within 2 business days, as...
The Centers for Disease Control and Prevention (CDC) awarded a $245,828.32 firm-fixed-price purchase order to Illumina, Inc. for annual maintenance services on Illumina instruments, including the NextSeq1000 and MiSeq, for a 5-year period from September 9, 2024 through September 8, 2029. The services include health checks, preventive maintenance, and repairs as needed. This purchase order was competed with no set-aside designation. Illumina is a manufacturer of sequencing and array-based...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents, for the maintenance of laboratory equipment. The contract has a ceiling value of $14,329.00 and a performance period ending on July 20, 2024. The award does not utilize any set-aside provisions. Illumina has a history of providing sequencing systems, reagents, and services to support...
This is a firm fixed price delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract, valued at $80,865.64, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to support the CDC's genomic research and analysis needs. This order is placed under the broader ILLUMINA BOA contract vehicle, which is an...
This is a firm fixed price purchase order contract awarded to Illumina, Inc., a manufacturer of genomic sequencing and analysis products, by the Centers for Disease Control and Prevention (CDC). The $90,260.40 contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies. This award appears to be for the provision of Illumina's sequencing...
This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $12,944.40, is for the maintenance of Illumina equipment. It does not have a set-aside designation. Illumina has a history of providing a range of genomic sequencing systems, reagents, and support services to various federal agencies, including the...